Literature DB >> 463940

Electrophysiologic studies of perphenazine and protriptyline in a patient with psychotropic drug-induced ventricular fibrillation.

R D Magorien, G M Jewell, S F Schaal, C V Leier.   

Abstract

A 51 year old woman sustained ventricular fibrillation while receiving perphenazine and protriptyline. After successful resuscitation and clinical stabilization, cardiac electrophysiologic studies were performed before and after the administration of each of these medications. Perphenazine widened the ventricular echo zone and facilitated induction of short salvoes of ventricular tachycardia (repetitive ventricular response). Protriptyline also widened the ventricular echo zone and allowed easy induction of long runs of ventricular tachycardia. Both psychotropic agents increased the incidence of ventricular dysrhythmias in this patient. The electrophysiologic study is a useful technique in determining the interaction between psychotropic drugs and life-threatening arrhythmias; it may provide a means of identifying the patients with cardiac disease in whom administration of these agents may be fatal.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 463940     DOI: 10.1016/0002-9343(79)90414-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

Review 1.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Cardiotoxicity associated with an intentional overdose of maprotiline and perphenazine: a case report.

Authors:  D T Jolly; I G Stiell
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

3.  Effect of antipsychotic drug perphenazine on fast sodium current and transient outward potassium current in rat ventricular myocytes.

Authors:  Markéta Bébarová; Peter Matejovic; Michal Pásek; Dagmar Jansová; Milena Simurdová; Marie Nováková; Jirí Simurda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-09       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.